SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0.
نویسندگان
چکیده
1Seattle Nuclear Medicine, Seattle, Washington; 2Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 3University of Michigan Medical Center, Ann Arbor, Michigan; 4Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 5The Synaptic Space, Centennial, Colorado; 6Wolfson Molecular Imaging Centre, Manchester, England; 7University of Washington, Seattle, Washington; 8Austin Hospital, Melbourne, Australia; 9University Hospital Leipzig, Leipzig, Saxony, Germany; 10Institute for Neurodegenerative Disorders, New Haven, Connecticut; 11VU University Medical Center Amsterdam, Amsterdam, The Netherlands; and 12University of Washington, Seattle, Washington
منابع مشابه
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
The diagnosis of movement disorders including Parkinson's disease (PD) and essential tremor is determined through clinical assessment. The difficulty with diagnosis of early PD has been highlighted in several recent clinical trials. Studies have suggested relatively high clinical diagnostic error rates for PD and essential tremor. This review was undertaken to clarify the utility of DaT-SPECT i...
متن کاملImprovement of diagnostic accuracy of Parkinson's disease on I-123-ioflupane single photon emission computed tomography (123I FP-CIT SPECT) using new Japanese normal database
Objective(s): I-123-ioflupane single photon emission computed tomography (FP-CIT-SPECT) has been used to assess dopamine transporter (DAT) loss in Parkinson's disease. The specific binding ratio (SBR), a quantitative parameter of DAT density in the striatum, may be affected by differences in age, sex, and SPECT system. The purpose of this study was to evaluate the util...
متن کاملClinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (I) ioflupane in diagnosis of parkinsonian syndromes
To cite: Bajaj N, Hauser RA, Grachev ID. J Neurol Neurosurg Psychiatry Published Online First: [please include Day Month Year] doi:10.1136/jnnp2012-304436 ABSTRACT The diagnosis of movement disorders including Parkinson’s disease (PD) and essential tremor is determined through clinical assessment. The difficulty with diagnosis of early PD has been highlighted in several recent clinical trials. ...
متن کاملThe role of 123I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
The diagnosis of dementia with Lewy bodies (DLB) is difficult if one relies solely on clinical features. Current International Consensus Criteria for DLB have high specificity but a significant percentage of patients might be misdiagnosed. Reasons for clinical uncertainty regard the presence of concomitant motor signs in patients with Alzheimer's disease as well as the observation that cognitiv...
متن کاملAccumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
Background: Selegiline enhances the patient's endogenous dopamine by inhibiting dopamine metabolism. The efficacy of selegiline monotherapy for drug-naïve Parkinson's disease (PD) patients may depend on the degree of dopaminergic neuronal degeneration. 123I-Ioflupane single photon emission computed tomography (SPECT) and 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy are diagnosti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
دوره 53 1 شماره
صفحات -
تاریخ انتشار 2012